Elevance Health, Inc.

ELV · Large cap · 1 article

Financial highlights

Metric	FY 12/31/25	FY 12/31/24	FY 12/31/23	FY 12/31/22	FY 12/31/21
Income Statement
Revenue	$199.1B	$177.0B	$171.3B	$156.6B	$138.6B
Selling, general & administrative	$21.0B	$20.0B	$20.1B	$17.7B	$15.9B
Operating income	$7.2B	$7.9B	$8.5B	$8.3B	$7.6B
Interest expense	$1.4B	$1.2B	$1.0B	$851.0M	$798.0M
Pretax income	$6.7B	$7.9B	$7.7B	$7.6B	$7.9B
Income tax expense	$1.0B	$1.9B	$1.7B	$1.7B	$1.8B
Net income	$5.7B	$6.0B	$6.0B	$5.9B	$6.2B
Balance Sheet
Cash and equivalents	$9.5B	$8.3B	$6.5B	$7.4B	$4.9B
Current assets	$63.0B	$58.9B	$60.0B	$55.6B	$51.1B
Total assets	$121.5B	$116.9B	$108.9B	$102.8B	$97.5B
Current liabilities	$41.0B	$40.6B	$41.8B	$39.7B	$34.9B
Total liabilities	$77.5B	$75.5B	$69.5B	$66.4B	$61.3B
Stockholders' equity	$43.9B	$41.3B	$39.3B	$36.2B	$36.1B
Cash Flow Statement
Cash from operations	$4.3B	$5.8B	$8.1B	$8.4B	$8.4B
Depreciation and amortization	$1.5B	$1.4B	$1.7B	$1.7B	$1.3B
Stock-based compensation	$276.0M	$191.0M	$289.0M	$264.0M	$255.0M
Capital expenditure	$1.1B	$1.3B	$1.3B	$1.2B	$1.1B
Free cash flow	$3.2B	$4.6B	$6.8B	$7.2B	$7.3B
Dividends paid	$1.5B	$1.5B	$1.4B	$1.2B	$1.1B
Share repurchases	$2.6B	$2.9B	$2.7B	$2.3B	$1.9B
Impairments	$108.0M	$103.0M	$446.0M	$7.0M	$73.0M

Shares outstanding 217.2M · Free float 99.8%

Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.